Rebamipide - Moligand™, 10mM in DMSO , Agonist of CCK 1 receptor, CAS No.90098-04-7, Agonist of CCK 1 receptor

CAS: 90098-04-7 Cat. No.: R408057 Summenformel: C₁₉H₁₅ClN₂O₄.xH₂O Molekulargewicht: 370.79 EG-Nummer: 815-380-0 PubChem CID: 5042

GRADE & PURITY Moligand™, 10mM in DMSO

Synonyms

OPC-12759 | α-​[(4-​chlorobenzoyl)​amino]​-​1,​2-​dihydro-​2-​oxo-4-​quinolinepropanoic acid

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

Übersicht

Information

Rebamipide Rebamipide (OPC-12759) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [ 125 I]BH-CCK-8S with IC50 of 37.7 μM.
In vitro

In vivo

Cell Data

cell lines：

Concentrations：

Incubation Time：

Powder Purity:≥99%

Specifications

Synonyme

OPC-12759 | α-​[(4-​chlorobenzoyl)​amino]​-​1,​2-​dihydro-​2-​oxo-4-​quinolinepropanoic acid

Spezifikationen & Reinheit

Moligand™, 10mM in DMSO

Biochemische und physiologische Mechanismen

Rebamipide (OPC-12759) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [¹²⁵I]BH-CCK-8S with IC50 of 37.7 μM.

Storage

Store at -80°C

Verschickt in

Dry ice packs + Cold packs

Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.

Note

Moligand™

Aktionsart

AGONIST

Mechanismus der Wirkung

Agonist of CCK 1 receptor

Namen und Kennungen

• Isomere SMILES: C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
• RTECS: VC2518500
• PubChem CID: 5042
• Molekulargewicht: 370.79
• Reaxy-Rn: 5384689

Zugehörige Ziele (menschlich)

CCKAR Tclin Cholecystokinin receptor type A (1 Activities)

Discover Target: CCKAR

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Chemische und physikalische Eigenschaften

• Schmelzpunkt (°C): 290°C(dec.)(lit.)

Referenzen

1. Han Qiao, Zhuo Xu, Mengchi Sun, Shuwen Fu, Fangxue Zhao, Danping Wang, Zhonggui He, Yinglei Zhai, Jin Sun.  (2022)  Rebamipide liposome as an effective ocular delivery system for the management of dry eye disease.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,      [PMID:] [10.1016/j.jddst.2022.103654]